Today: 7 February 2026
Subscribe

Oklo stock ends 2025 near $72: what’s driving OKLO and what investors watch next

Oklo stock ends 2025 near $72: what’s driving OKLO and what investors watch next

NEW YORK, December 31, 2025, 21:05 ET — Market closed Oklo Inc. shares were last up about 0.2% at $71.76 on Wednesday after the U.S. market close, capping a muted year-end session for the nuclear start-up. The near-flat finish matters because Oklo’s stock has been driven less by current earnings and more by expectations for when it can license and deploy its first reactors. That puts investors’ attention on regulatory timelines and how the company funds its buildout. Oklo+1 Oklo is developing what it calls the Aurora “powerhouse,” part of a wave of so-called small modular reactors (SMRs) — smaller
1 January 2026
········
Marvell (MRVL) stock drops 2% into year-end close as chip trade cools — what’s next

Marvell (MRVL) stock drops 2% into year-end close as chip trade cools — what’s next

NEW YORK, December 31, 2025, 21:09 ET — Market closed Marvell Technology (MRVL.O) fell $1.78, or about 2.1%, to $84.98 on Wednesday. Trading volume was about 7.2 million shares. The decline came as Wall Street ended 2025’s final session lower in holiday-thin trade, with the Nasdaq down 0.76% and the S&P 500 off 0.74%, Reuters reported. “It’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity, pointing to profit-taking when liquidity was low. Reuters The year-end drift matters because the market’s gains have been driven by the artificial intelligence trade,
1 January 2026
·····
Caterpillar stock ends 2025 lower — what investors are watching for CAT in January

Caterpillar stock ends 2025 lower — what investors are watching for CAT in January

NEW YORK, December 31, 2025, 21:11 ET — Market closed Caterpillar Inc shares slipped about 0.8% on Wednesday to close at $572.87, as U.S. stocks ended the year’s final session lower. MarketWatch+1 The move matters because Caterpillar is widely treated as a read-through on capital spending, from construction equipment to mining and energy projects. With 2026 starting amid shifting rate expectations and trade uncertainty, investors are using late-year price action as a quick gauge of risk appetite. Reuters Caterpillar is also coming off a strong 2025 run, leaving the stock more sensitive to profit-taking and any reset in expectations around
1 January 2026
·····
Citigroup stock ends 2025 lower after $1.2 billion Russia-exit loss disclosure — what investors watch next

Citigroup stock ends 2025 lower after $1.2 billion Russia-exit loss disclosure — what investors watch next

Citigroup stock ends 2025 lower after $1.2 billion Russia-exit loss disclosure — what investors watch next NEW YORK, December 31, 2025, 20:50 ET — Market closed Citigroup shares ended 0.4% lower on Wednesday after the bank disclosed that the planned sale of its remaining Russia business would trigger about $1.2 billion in pre-tax losses. Reuters The move matters heading into mid-January bank earnings because the loss will weigh on Citi’s fourth-quarter headline results at a time investors are focused on whether the lender’s multi-year overhaul is lifting returns and simplifying the balance sheet. Citi said the loss is largely tied
1 January 2026
····
GE Aerospace stock slips into year-end close — what investors watch next

GE Aerospace stock slips into year-end close — what investors watch next

NEW YORK, December 31, 2025, 20:50 ET — Market closed GE Aerospace shares closed down 1.2% on Wednesday at $308.03, trimming year-end gains after a strong run through 2025. The stock still ended the year up about 85%, based on its Dec. 31, 2024 close of $166.79. Chase ID Center The late-year dip matters because GE has been one of the market’s standout industrial winners, leaving less room for disappointment as investors reset portfolios for 2026. Traders are using the last prints of the year to gauge whether aerospace leaders can hold premium valuations into a January stretch packed with
1 January 2026
·····
Lam Research stock slips into year-end close — what traders watch next for LRCX

Lam Research stock slips into year-end close — what traders watch next for LRCX

NEW YORK, December 31, 2025, 20:53 ET — Market closed Lam Research Corp shares fell 1.5% to $171.18 on Wednesday, extending a three-session slide as the chip equipment maker closed out the final trading day of 2025. MarketWatch The decline came as Wall Street finished the year with modest losses in thin holiday trading, with the S&P 500 down 0.74% and the Nasdaq off 0.76%, Reuters reported. Reuters That matters now because Lam is a bellwether for wafer fabrication equipment — the costly chipmaking tools used to build semiconductors — and positioning into 2026 is being driven by expectations for
1 January 2026
····
Mastercard stock ends 2025 lower as Wall Street slips — what’s next for MA shares

Mastercard stock ends 2025 lower as Wall Street slips — what’s next for MA shares

NEW YORK, December 31, 2025, 20:52 ET — Market closed Mastercard Incorporated shares fell 1.13% on Wednesday to close at $570.88, after trading between $570.79 and $578.00. The late-year dip matters because investors often treat card networks like Mastercard as read-throughs on consumer and business spending, especially into the first data-heavy weeks of a new year. It also lands at a moment when portfolio managers are resetting risk after a strong 2025, with interest-rate expectations and economic momentum likely to steer early-2026 positioning. Wall Street’s main indexes ended 2025 lower in holiday-thin trading, with the S&P 500 down 0.74%, and
1 January 2026
·····
Nebius Group (NBIS) stock falls as insider sale filings surface ahead of Jan. 2 trading restart

Nebius Group (NBIS) stock falls as insider sale filings surface ahead of Jan. 2 trading restart

NEW YORK, December 31, 2025, 20:44 ET — Market closed Nebius Group N.V. shares ended down 1.7% at $83.71 on Wednesday, after U.S. filings showed several insiders planned sales of the company’s Class A ordinary shares in early January. The stock traded between $82.94 and $86.41, with about 7.1 million shares changing hands. The disclosure matters because Nebius has been a high-beta proxy for the AI infrastructure buildout, where sentiment can swing quickly on any sign of incremental supply. Investors in the group have also been focused on dilution risk and funding needs as the company ramps capacity. Timing adds
1 January 2026
·····
Qualcomm stock slides in thin year-end trade; QCOM turns to Feb. 4 earnings next

Qualcomm stock slides in thin year-end trade; QCOM turns to Feb. 4 earnings next

NEW YORK, December 31, 2025, 20:43 ET — Market closed QUALCOMM Incorporated (QCOM) ended Wednesday down 1.5% at $171.05, giving back ground in the final U.S. trading session of 2025. MarketWatch The stock fell as Wall Street closed the year modestly lower, with the S&P 500 down 0.74% and the Nasdaq off 0.76%, Reuters reported. Reuters That matters now because year-end trading is often thin, and small orders can move prices more than usual. Traders pointed to profit-taking — selling to lock in gains — when liquidity is low, meaning fewer buyers and sellers are active. Reuters “It’s perfectly fine
1 January 2026
····
Johnson & Johnson stock ends 2025 steady as Halda deal closes and Barclays hikes target

Johnson & Johnson stock ends 2025 steady as Halda deal closes and Barclays hikes target

NEW YORK, December 31, 2025, 8:48 PM ET — Market closed Johnson & Johnson (JNJ) shares eked out a 0.02% gain to $206.95 on Wednesday, a rare green finish as U.S. stocks slipped in the final session of 2025. The S&P 500 fell 0.74% and the Dow lost 0.63%. MarketWatch The muted close leaves investors searching for a clean catalyst after a strong year for the stock. The next big read comes when management updates guidance and lays out how recent deals will flow through earnings. That focus sharpened this week after the company said it completed its $3.05 billion
1 January 2026
····
Sandisk sets Jan. 29 earnings date; SNDK dips after-hours as NAND outlook comes into focus

Sandisk sets Jan. 29 earnings date; SNDK dips after-hours as NAND outlook comes into focus

NEW YORK, December 31, 2025, 19:48 ET Sandisk Corp said it will report fiscal second-quarter results on Jan. 29, 2026, and host an earnings conference call at 1:30 p.m. Pacific time (4:30 p.m. ET), with a live webcast and replay available online. Business Wire Shares of the Nasdaq-listed flash-memory maker were down about 1.2% at $237.38 in after-hours trading on Wednesday, with Western Digital, Seagate Technology and Micron Technology also lower. Traders have been sizing up year-end profit-taking after Sandisk’s outsized 2025 run, with investors focused on whether NAND flash — memory chips used in solid-state drives — can maintain
1 January 2026
·····
10% yield play on Lululemon draws options interest as SM Energy tops investor search lists

10% yield play on Lululemon draws options interest as SM Energy tops investor search lists

NEW YORK, December 31, 2025, 19:49 ET A new options trade pitch targeting about a 10% annualized return is putting Lululemon Athletica back on investors’ screens as the stock trades far below its highs. The setup matters now because investors are trying to balance two competing forces: bargain hunting after sharp drawdowns and the appeal of cash-like returns that can be earned while waiting. It also shows how options — once mainly the domain of professionals — are increasingly being used as a “paid waiting” strategy, especially when shares are volatile and valuations are in focus. Trefis said Lululemon (LULU)
1 January 2026
······
1 … 1,043 1,044 1,045 1,046 1,047 … 2,711

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Go toTop